Capuzzi, E.; Caldiroli, A.; Capellazzi, M.; Tagliabue, I.; Marcatili, M.; Colmegna, F.; Clerici, M.; Buoli, M.; Dakanalis, A.
Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review. Int. J. Mol. Sci. 2021, 22, 9338.
https://doi.org/10.3390/ijms22179338
AMA Style
Capuzzi E, Caldiroli A, Capellazzi M, Tagliabue I, Marcatili M, Colmegna F, Clerici M, Buoli M, Dakanalis A.
Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review. International Journal of Molecular Sciences. 2021; 22(17):9338.
https://doi.org/10.3390/ijms22179338
Chicago/Turabian Style
Capuzzi, Enrico, Alice Caldiroli, Martina Capellazzi, Ilaria Tagliabue, Matteo Marcatili, Fabrizia Colmegna, Massimo Clerici, Massimiliano Buoli, and Antonios Dakanalis.
2021. "Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review" International Journal of Molecular Sciences 22, no. 17: 9338.
https://doi.org/10.3390/ijms22179338
APA Style
Capuzzi, E., Caldiroli, A., Capellazzi, M., Tagliabue, I., Marcatili, M., Colmegna, F., Clerici, M., Buoli, M., & Dakanalis, A.
(2021). Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review. International Journal of Molecular Sciences, 22(17), 9338.
https://doi.org/10.3390/ijms22179338